Constellation Healthcare Technologies, Inc.

30/09/2016

Interim Results for the Six Months Ended 30th June 2016

Key Performance Indicators

 

     

Interim 2016

Interim 2015

FY- 2015

REVENUE

 

+78%

$57.0

*

$32.0

*

$76.7

*

Income from Operations

 

+92%

$14.5

25%

$7.6

24%

$19.2

25%

Profit Before Tax

 

+267%

$15.4

27%

$4.2

13%

$11.4

15%

EBITDA

 

+121%

$21.1

37%

$9.6

30%

$23.9

31%

RCM Revenue

 

+110%

$43.6

76%

$20.7

65%

$50.1

65%

RCM EBITDA

 

+139%

$16.8

29%

$7.0

22%

$16.1

21%

CASH FROM OPERATIONS

+160%

$10.9

19%

$4.2

13%

$15.5

20%

 * % of revenue

All amounts USD$M

Highlights

  • Revenue Increased by 78% to $57.0M ($32.0M in 2015)
  • 22% organic growth in the RCM business
  • Cash from Operations increased by 19% to $10.9M ($4.2M in 2015)
  • Debt facility paid down in full from internal cash generation
  • 10,000+ US Physicians currently being serviced
  • RCM business revenue increased by 110% to $43.6M ($20.7M in 2015)
  • RCM EBITDA increased by 139% to $16.8M ($7.0M in 2015)
  • Successful acquisition and integration of MDRX Medical Billing
  • Further strengthening of the board with the appointment of Dr. Shawn Zimberg

Paul Parmar, Chief Executive of Constellation Healthcare Technologies, commented, “CHT has built a robust platform based on its efficient RCM processes and technologies. Coupled with a tried, tested and matured methodology of integrating and transitioning new clients and new business onto this highly scalable platform, this platform and experience allows CHT to rapid growth.

We are now starting to see the benefits of this investment as evidenced by the 78% increase in revenues with 22% of the revenue coming from organic growth and very strong cash generated from operations as evidenced by a 160% increase as compared to the same period last year. We strongly believe that our platform and our integration methodology along with the experience we have gained, uniquely places us to grow the business rapidly through organic growth and M&A.

At this point in time we feel very confident having delivered above  expectations for the first half of 2016, that we will meet the markets guidance on revenue as well as profits for the full year 2016.